* indicates a required field
Abstract Submission Guidelines
Abstract submitters must complete all submission requirements by 11:59 pm EDT on August 2, 2021 for the abstract to enter the review process and be considered for virtual poster presentation. An abstract deadline extension is not planned. There will be no additional deadlines for late-breaking data.
Abstract Submitter Requirements
It is expected that the abstract submitter, lead author and poster presenter (should the abstract be accepted) are one and the same. The abstract submitter must meet the following requirements:
- Be an oncology/hematology advanced practitioner (AP) defined as a nurse practitioner (NP), physician assistant (PA), pharmacist (PharmD), clinical nurse specialist (CNS), or master's degree or higher advanced practice nurse;
- Be a member of the Advanced Practitioner Society for Hematology and Oncology (APSHO) in good standing (please see below for more information);
- Complete all requirements of abstract submission; and
- Attend the virtual conference and present a poster should the abstract be accepted.
Information and Tasks Required for Abstract Submission
An abstract submission must include the following information and be electronically submitted by the deadline. Information and tasks by author type include:
- Full name, credentials, title/position, institution, email, phone number and APSHO membership number
- Curriculum vitae (CV) or resume
- Completed disclosure form (each author on the abstract must complete one)
- Final abstract title
- Complete body of abstract including appropriate subheadings
- Declaration of the role of the authors in the work/content presented in the abstract
- Confirmation of original authorship (completed by the submitting author)
- Completed Copyright Transfer Agreement for Abstracts (lead or representative author approved by the lead author must complete)
- Permissions if applicable (may be uploaded as supporting documentation)
- References (encouraged but not required; may be uploaded as supporting documentation)
- Full name, credentials, title/position, institution, email, and phone number
- Self-completed disclosure forms (each author listed on the abstract must complete one)
Abstract Instructions and Additional Requirements
Authors are advised to make certain the abstract addresses the significance of the topic for oncology advanced practice and provides a clear description of the role of, and implications for, advanced practitioners in oncology. In addition:
- Abstract content must be objective and free of bias.
- Content must be original, novel, significant for advanced practitioners, not previously presented or published, and not submitted for consideration elsewhere.
- Content should describe a completed initiative (see below for more information regarding complete or incomplete initiatives.
- Encore abstracts and abstracts discussing trials in progress will not be considered for review.
Submitters will be required to identify the topic of the abstract. Abstract topics may include:
- Clinical/evidence-based practice
- Educational initiatives
- Professional development
- Advanced practice projects
Submitters will be asked to designate a category for the abstract. Categories include:
- Original Research/Evidence-based Practice
- Quality of Care
- Professional Development
The title at the time of submission will be the final title used in all references to the abstract, including the poster, poster listings, and publication in the Journal of the Advanced Practitioner in Oncology (JADPRO) should the abstract be accepted. Acronyms and brand names of drugs are not permitted in the title. The title is not included in the word count.
Abstracts should be no more than 500 words, including section headings.
The abstract must be organized with section headings. Example section headings:
- Background (other options: Context, Setting, Objective, Aim, Goal, Purpose)
- Methods (other options: Design, Intervention, Approaches, Procedures, Processes)
- Results (other options: Findings, Outcome Measures, Effects, Discoveries)
- Conclusions (other options: Interpretation, Summary, Evaluation)
- Recommendations (other options: Implications, Proposals, Applications)
Tables are not allowed within abstracts but may be used on posters.
Mention of drugs/therapies
Generic names may be used for drug mentions in abstracts and abstract titles.
References and Permissions
References and/or permissions may be uploaded as separate documents and therefore will not be included in the word count. PDF is preferred; .doc and .docx may also be used.
Projects in Progress and Late-breaking Data
Abstracts should describe completed work; projects in progress may be considered for review if the content provided is compelling and important for the advanced practitioner prior to project completion. Late-breaking data past the submission deadline may be included in the poster should the abstract be accepted. Please contact the abstract coordinator for questions or concerns.
A maximum of 10 authors is allowed. The submitting author may be contacted to clarify co-author information, role or contributions. All correspondence regarding a submitted abstract will be directed to the submitting author. Once the deadline has passed, changes to the abstract submission, including authorship, are not permitted. If there are questions regarding author inclusions, or concerns regarding presentation of a potential poster, please contact the abstract coordinator. Abstracts may not be written or submitted by parties on behalf of authors; submissions of this type will be declined.
An advanced practitioner who submits an abstract must be a current, dues-paying member of APSHO in good standing and have a completed member profile. For more information regarding your current membership status or to join APSHO, please visit www.apsho.org.
Tips for a Successful Abstract Submission
- Learn more about how abstracts will be reviewed. Read and note the criteria in the Review Process below.
- Submit early and allow time for co-authors to complete their tasks electronically.
- Ask questions! Contact the abstract coordinator listed below.
- Don't forget to hit the submit button once all abstract information is entered and tasks are completed.
- Understand what is required once an abstract is accepted. Read the information on posters below.
All completed abstract submissions that meet requirements will undergo review, including review by two or more peer reviewers utilizing a double-blind review process via the electronic submission system. (Authors and peer reviewers will remain unknown to each other.) The submitting author may contact the abstract coordinator for questions throughout the process. The abstract coordinator may contact submitting authors with questions regarding abstract submissions.
Abstract peer review criteria
Category 1: Background (Context, Setting, Objective, Aim, Goal, Purpose)
- The background is clearly summarized.
- The purpose/significance (of the educational topic, clinical project/issue, leadership or professional activity or research) is clearly defined and directed to oncology advanced practice.
- The topic/content has implications for the oncology advanced practitioner.
- The role of the oncology advanced practitioner is distinctly described.
- How the purpose/objective was addressed is included.
- The implementation methods (interventions, approaches, procedures, and/or processes) are clearly described.
- The goals are evaluated according to specific measures.
- The outcomes are applicable to and valuable for oncology advanced practitioners.
- The outcomes and findings are clearly summarized and discussed.
- The implications for oncology advanced practice are clearly identified.
- Suggestions, recommendations and/or next steps are included and applicable for APs or to oncology advanced practice.
- The research, clinical/evidence-based practice project or oncology advanced practice initiative/activity is innovative, fresh, creative or ground-breaking.
Accepted abstracts will be eligible for poster presentation during JADPRO Live Virtual, October 7–10, and October 14–17, 2021. For more information regarding JADPRO Live Virtual, please visit the conference website, www.jadprolive.com.
Accepted abstracts will be published in an issue of JADPRO following the conference. Publication of the abstract will not jeopardize future submission of a manuscript; authors are encouraged to continue their work to manuscript submission.
Submitting authors whose abstracts are accepted for poster presentation will be contacted by the abstract coordinator with additional details and next steps in the process, including, but not limited to, poster numbers or other identifiers, specifications for poster development, author tasks, presentation dates and times, and any additional requirements for final approval.
The presenting author will have tasks to complete in the electronic system, with deadlines, such as:
- Confirming the author profile information
- Uploading an author photo
- Uploading an author bio
- Uploading the final poster in PDF format
- Providing the JADPRO Live Virtual registration confirmation number
Accepted abstracts, posters and presenting author information will be available to registered conference attendees via the conference virtual platform. Posters will be available via poster gallery on the JADPRO Live website at specific times during the conference.
Outstanding Poster Award
The annual APSHO Outstanding Poster Award will be presented during JADPRO Live Virtual. The Poster Award Review Task Force will use the same abstract peer review criteria (see review categories above) to consider all abstract posters submitted by the poster upload deadline and will select the Outstanding Poster Award winner. The poster award winner will receive special recognition during JADPRO Live Virtual, recognition in the meeting coverage issue of JADPRO following the conference, and recognition in the APSHO Advance member newsletter.
To be eligible for the award, the final pdf of the poster for the accepted abstract must be uploaded to the electronic submission system by 5 pm EDT on Monday, September 27, 2021.
Accessing the Submission System
Submitting authors may access the abstract submission system below. After reading the guidelines, the submitting author should click on “Create Account” under the New Users area to create an account for the submission system. Once an account is created, the submitting author will be able to access the abstract up until the submission deadline. Submissions that are incomplete at the time of the deadline will no longer be accessible.
A copy of the full submission guidelines is also available for download once you are logged into the system.
For questions or concerns regarding abstracts and posters for JADPRO Live Virtual, please contact the abstract coordinator, Kelley Moore, at firstname.lastname@example.org.